Literature DB >> 9374260

A comparative study of polyacrylic acid (Viscotears) liquid gel versus polyvinylalcohol in the treatment of dry eyes.

J Brodwall1, G Alme, S Gedde-Dahl, J Smith, N P Lilliedahl, P A Kunz, P Sunderraj.   

Abstract

We conducted a prospective, randomised, single-masked study comparing the safety and efficacy of polyacrylic acid 0.2% (PAA) and polyvinylalcohol 1.4% (PVA) in 85 patients (PAA 43, PVA 42) with dry eyes. The two groups were similar in patient demographics and study parameters at baseline. With treatment, the reduction in total symptoms (gritty or foreign body sensation, burning sensation, dry eye sensation, photophobia, others) and signs (conjunctival hyperaemia, ciliary injection, corneal and conjunctival epithelial staining) score on PAA was significantly greater than that on PVA at both two and four weeks. The daily frequency of instillation of PAA was significantly less than that of PVA on 16 of the 27 (59%) study days. For overall local tolerance there was a significant preference for PAA compared to PVA by both patients and doctors. Only one patient on each treatment had an adverse event and neither was serious. PAA (Viscotears) was as safe as, but better tolerated and more effective than PVA in the treatment of dry eye conditions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9374260     DOI: 10.1111/j.1600-0420.1997.tb00413.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  4 in total

1.  A comparative assessment of the efficacy of carbomer gel and carboxymethyl cellulose containing artificial tears in dry eyes.

Authors:  Qing Xiao; Yanhua Hu; Fei Chen; Xiaomin Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-10-10

Review 2.  Timolol 0.1% in Glaucomatous Patients: Efficacy, Tolerance, and Quality of Life.

Authors:  Letizia Negri; Antonio Ferreras; Michele Iester
Journal:  J Ophthalmol       Date:  2019-05-02       Impact factor: 1.909

Review 3.  Over the counter (OTC) artificial tear drops for dry eye syndrome.

Authors:  Andrew D Pucker; Sueko M Ng; Jason J Nichols
Journal:  Cochrane Database Syst Rev       Date:  2016-02-23

4.  Ophthalmic Solution Safety Profile: Active Surveillance of a Sodium Hyaluronate/Chondroitin Sulfate Combination in Peruvian Population.

Authors:  Homero Contreras-Salinas; Mariana Barajas-Hernández; Leopoldo Martín Baiza-Durán; Vanessa Orozco-Ceja; Lourdes Yolotzin Rodríguez-Herrera
Journal:  Drug Healthc Patient Saf       Date:  2021-05-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.